InVivo Therapeutics Appoints Interim CEO, CFO to Replace Francis Reynolds

Spinal Tech

InVivo Therapeutics Holdings has appointed Michael J. Astrue as interim CEO and Sean Moran as acting CFO in the wake of former CEO and CFO Francis Reynolds resigning his posts due to a medical condition, according to a Hispanic Business report.

Mr. Moran currently serves as the company's director of finance. Mr. Astrue is the non-executive chairman of the board at Vivus biopharmaceutical company. Both appointments are effective immediately.

InVivo's board of directors will conduct a search for a permanent CEO throughout the year.

More Articles on Devices:
7 Spine-Focused Device Company Financial Reports
Zimmer PSI Shoulder System Receives FDA 510(k) Clearance
Hoag Memorial Hospital Adopts SECURE-C Cervical Disc Treatment

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers